(Q48031825)

English

Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines

scientific article published on 12 June 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16806600

Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16806600

Plasmodium falciparum

0 references

6

object named as

Liwang Cui

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

author name string

Jun Miao

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16806600

Xun Li

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16806600

Zhongxiang Liu

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16806600

Caifang Xue

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16806600

Hermann Bujard

5

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16806600

language of work or name

0 references

publication date

12 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16806600

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16806600

24

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16806600

37-39

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16806600

6187-6198

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16806600

The economic and social burden of malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Progress and challenges for malaria vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Towards a blood-stage vaccine for malaria: are we following all the leads?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Integral membrane protein located in the apical complex of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

The disulfide bond structure of Plasmodium apical membrane antigen-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Crystal structure of the malaria vaccine candidate apical membrane antigen 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Functional analysis of Plasmodium falciparum apical membrane antigen 1 utilizing interspecies domains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

High prevalence of natural antibodies against Plasmodium falciparum 83-kilodalton apical membrane antigen (PF83/AMA-1) as detected by capture-enzyme-linked immunosorbent assay using full-length baculovirus recombinant PF83/AMA-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Longitudinal study of natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in a holoendemic region of malaria in western Kenya: Asembo Bay Cohort Project VIII.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

The Fab fragments of monoclonal IgG to a merozoite surface antigen inhibit Plasmodium knowlesi invasion of erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Specificity of the protective antibody response to apical membrane antigen 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Induction of parasite growth-inhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Vaccination trials in rhesus monkeys with a minor, invariant, Plasmodium knowlesi 66 kD merozoite antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of Plasmodium fragile.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Definition of T cell epitopes within the 19 kDa carboxylterminal fragment of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) and their role in immunity to malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

CD4+ T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Immune effector mechanisms in malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

The complexity of protective immunity against liver-stage malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

DNA-based vaccines against malaria: status and promise of the Multi-Stage Malaria DNA Vaccine Operation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

DNA prime-protein boost immunization in monkeys: efficacy of a novel construct containing functional domains of Plasmodium cynomolgi CS and TRAP.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Characterization of antibody responses to a Plasmodium falciparum blood-stage antigen induced by a DNA prime/protein boost immunization protocol

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Prime-boost strategies for malaria vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Progress in DNA-based heterologous prime-boost immunization strategies for malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Human malaria parasites in continuous culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Plasmodium falciparum: differential display analysis of gene expression during gametocytogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Characterization of PfPuf2, member of the Puf family RNA-binding proteins from the malaria parasite Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Differential localization of full-length and processed forms of PF83/AMA-1 an apical membrane antigen of Plasmodium falciparum merozoites.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Proteolytic processing and primary structure of Plasmodium falciparum apical membrane antigen-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Pre-erythrocytic immunity to Plasmodium falciparum: the case for an LSA-1 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Production of the subdomains of the Plasmodium falciparum apical membrane antigen 1 ectodomain and analysis of the immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Fusion of two malaria vaccine candidate antigens enhances product yield, immunogenicity, and antibody-mediated inhibition of parasite growth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Protection of rhesus macaques against lethal Plasmodium knowlesi malaria by a heterologous DNA priming and poxvirus boosting immunization regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

Antibody-independent immunity to reinfection malaria in B-cell-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.099

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2006.05.099

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16806600

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16806600

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48031825&oldid=2181986111"